Capital Expenditures for DaVita (DVA)
According to DaVita's latest reported financial statements, the company's current capital expenditures (TTM) is $575.86M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
DVA
Currently viewingCapital ExpendituresSwitch metric
Latest period
$575.86M
YoY change
+3.7%
5Y CAGR
-3.1%
Peak year (2018)
$987.14M
Cumulative capital expenditures
$12.63B
CapEx history chart for DaVita (DVA) from 1994 to 2025
CapEx history table for DaVita (DVA) from 1994 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $575.86M | +3.7% | ||
| 2024 | $555.44M | -2.2% | ||
| 2023 | $567.99M | -5.9% | ||
| 2022 | $603.43M | -5.9% | ||
| 2021 | $641.47M | -4.9% | ||
| 2020 | $674.54M | -12.0% | ||
| 2019 | $766.55M | -22.3% | ||
| 2018 | $987.14M | +9.0% | ||
| 2017 | $905.25M | +9.2% | ||
| 2016 | $829.10M | +17.1% | ||
| 2015 | $708.00M | +10.2% | ||
| 2014 | $642.35M | +3.4% | ||
| 2013 | $621.29M | +12.9% | ||
| 2012 | $550.15M | +37.5% | ||
| 2011 | $400.16M | +46.3% | ||
| 2010 | $273.60M | -0.5% | ||
| 2009 | $274.93M | -13.6% | ||
| 2008 | $318.03M | +15.9% | ||
| 2007 | $274.50M | +2.3% | ||
| 2006 | $268.31M | +66.3% | ||
| 2005 | $161.37M | +25.7% | ||
| 2004 | $128.33M | +28.0% | ||
| 2003 | $100.27M | -2.4% | ||
| 2002 | $102.71M | +100.5% | ||
| 2001 | $51.23M | +24.7% | ||
| 2000 | $41.09M | -61.5% | ||
| 1999 | $106.66M | -74.7% | ||
| 1998 | $421.20M | +1041.5% | ||
| 1997 | $36.90M | +11.8% | ||
| 1996 | $33.00M | +602.1% | ||
| 1995 | $4.70M | +23.7% | ||
| 1994 | $3.80M | — |
CapEx values are taken from DaVita's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, DaVita (DVA) reported capital expenditures of $575.86M – edged up 3.7% year-over-year.
Through 2020–2025 (5 years), DaVita capital expenditures delivered a -3.1% annualised rate; with a net decline across the window.
DaVita capital expenditures peaked at $987.14M in 2018; the latest annual figure is $575.86M in 2025 (41.7% below peak).
Across the available history, capital expenditures reached its high of $987.14M in 2018 and its low of $3.80M in 1994.
Among 8 Healthcare peers, DaVita (DVA) ranks 9th; the peer median for capital expenditures is $3.87B.
DaVita Capital Expenditures by Year
DaVita Capital Expenditures 2025: $575.86M
DaVita capital expenditures in 2025 was $575.86M, edged up 3.7% from 2024.
DaVita Capital Expenditures 2024: $555.44M
DaVita capital expenditures in 2024 was $555.44M, edged down 2.2% below 2023.
DaVita Capital Expenditures 2023: $567.99M
DaVita capital expenditures in 2023 was $567.99M, declined 5.9% below 2022.
DaVita Capital Expenditures 2022: $603.43M
DaVita capital expenditures in 2022 was $603.43M, declined 5.9% below 2021.
DaVita Capital Expenditures 2021: $641.47M
DaVita capital expenditures in 2021 was $641.47M.
See more financial history for DaVita (DVA).
Sector peers — CapEx
Companies in the same sector as DaVita, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is DaVita's capital expenditures?
- Latest reported capital expenditures for DaVita (DVA) is $575.86M (period ending December 31, 2025).
How has DaVita capital expenditures changed year-over-year?
- DaVita (DVA) capital expenditures changed +3.7% year-over-year on the latest annual filing.
What is the long-term growth rate of DaVita capital expenditures?
- DaVita (DVA) capital expenditures compound annual growth rate is -3.1% over the most recent 5 years available.
When did DaVita capital expenditures hit its highest annual value?
- DaVita capital expenditures reached its highest annual value of $987.14M in 2018.
What was DaVita capital expenditures in 2024?
- DaVita (DVA) capital expenditures in 2024 was $555.44M.
What was DaVita capital expenditures in 2025?
- DaVita (DVA) capital expenditures in 2025 was $575.86M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DVA Overview
Company profile, financial tools, and key metrics
DVA Revenue Counter
Earns $432.62 every second. See per minute, hour, and day.
DVA Earnings Counter
Earns $23.68 per second net profit. See per minute, hour, and day.
DVA Economic Scale
Exceeds Namibia's GDP. Compare with world economies.
DVA What If Invested
What if you had invested $1,000? See historical returns from any date.
DVA How It Makes Money
Discover visual breakdown of $13.64B in revenue — where it comes from and where it goes.
DVA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DVA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DVA Daily Price Character
Balanced · 50.5% historical win rate (green days). Streaks & record days.
DVA Buybacks
18.33% TTM buyback yield. Shareholder yield & SBC comparison.
DVA Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.